Author

Qinggui Meng

Observed names: QINGGUI MENG, Qing-Gui Meng, Qing-gui MENG

Institutions: Guangxi Medical University, Tumor Hospital of Guangxi Medical University

Observed institutions: Guangxi Medical University, Tumor Hospital of Guangxi Medical University

OpenAlex ID: A5082019718

Bone marrow-derived mesenchymal stem cells induced by inflammatory cytokines produce angiogenetic factors and promote prostate cancer growth

2017 · Ke-Qin Yang, Yan Liu, et al. · BMC Cancer · 49

Cystitis glandularis: A controversial premalignant lesion

2014 · XIANLIN YI, HAOYUAN LU, et al. · Oncology Letters · 40

The role of mesenchymal stem cells in promoting the transformation of androgen-dependent human prostate cancer cells into androgen-independent manner

2016 · Jiwen Cheng, Keqin Yang, et al. · Scientific Reports · 28

The enhanced expression of estrogen‐related receptor α in human bladder cancer tissues and the effects of estrogen‐related receptor α knockdown on bladder cancer cells

2019 · Xinqing Ye, Jinan Guo, et al. · Journal of Cellular Biochemistry · 23

Mesenchymal stem cells overexpressing Sirt1 inhibit prostate cancer growth by recruiting natural killer cells and macrophages

2016 · Yang Yu, Qingyun Zhang, et al. · Oncotarget · 21

Proxalutamide in metastatic castration‐resistant prostate cancer: Primary analysis of a multicenter, randomized, open‐label, phase 2 trial

2023 · Tie Zhou, Shengfei Qin, et al. · International Journal of Cancer · 9

Clinical Value of Postoperative Neutrophil-to-Lymphocyte Ratio Change as a Detection Marker of Bladder Cancer Recurrence

2021 · Qingyun Zhang, Qinqiao Lai, et al. · Cancer Management and Research · 8

Proteomic profiling of prostate cancer reveals molecular signatures under antiandrogen treatment

2024 · Yurun Huang, Guanglin Yang, et al. · Clinical Proteomics · 5

Muscarinic cholinergic signaling and overactive bladder‑like symptoms associated with invasive bladder cancer

2018 · Wei Wei, Minggang Wang, et al. · Oncology Letters · 4

A phase II, multicenter, randomized, open-label study to evaluate the safety and tolerability of proxalutamide (GT0918) in subjects with metastatic castrate-resistant prostate cancer (mCRPC).

2021 · Tie Zhou, Dingwei Ye, et al. · Journal of Clinical Oncology · 2

Interleukin-1α induces immunosuppression by mesenchymal stem cells in promoting the growth of prostate cancer cells

2014 · Jiwen Cheng, Qinggui Meng, et al. · Zhonghua miniao waike zazhi

Inhibitory effect of nitric oxide-donating aspirin against prostatic cancer angiogenesis in tumor-bearing mice

2010 · Ji-wen CHENG, Qing-gui MENG, et al. · Academic Journal of Second Military Medical University

[A case report of paclitaxel combined with carboplatin for poorly differentiated prostate cancer with renal failure].

2007 · Ji-Wen Chen, Qing-Gui Meng, et al. · PubMed

Works count: 13

Citation count: 189

H-index: 7

I10-index: 5